Literature DB >> 21102418

Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases.

Ankur R Sangoi1, Jason Karamchandani, Brooke Lane, John P Higgins, Robert V Rouse, James D Brooks, Jesse K McKenney.   

Abstract

Brachyury is recognized as a specific marker for notochord-derived tissues and neoplasms, and has become a defining immunohistochemical feature of chordoma. The main differential diagnostic consideration for chordoma is chondrosarcoma, which is known to lack brachyury expression. However, within the spectrum of genitourinary neoplasia, metastatic germ cell tumors and clear cell renal cell carcinoma may also be close morphological mimics of chordoma, particularly given the increasing prevalence of small tissue samples from image-guided biopsies. Although immunoreactivity for brachyury has been reported in a few germ cell tumors, a thorough characterization of staining by specific subtype has not been performed in a large series. Additionally, brachyury expression in clear cell renal cell carcinoma has not been well studied. In this study, immunohistochemical expression with the brachyury antibody was evaluated in 111 germ cell tumors, 30 non-neoplastic and neoplastic (non-germ cell) testicular tissues, and 184 metastatic clear cell renal cell carcinomas using tissue microarray technology. In addition, immunoreactivity for PAX-8 and SALL-4 was evaluated in 12 chordomas on whole section. No nuclear brachyury expression was identified in any of the 101 germ cell tumors within the tissue microarray (including choriocarcinoma (1), embryonal carcinoma (20), intratubular germ cell neoplasia unclassified (2), seminoma (64), spermatocytic seminoma (1), teratoma (5) and yolk sac tumor (8)), in any of the 30 non-neoplastic and neoplastic (non-germ cell) testicular tissues, or in any of the 10 whole-section seminomas. All 184 metastatic clear cell renal cell carcinomas were also non-reactive for brachyury. All 12 chordomas showed strong nuclear immunoreactivity for brachyury, but no expression of SALL-4. In all, 1 of 12 chordoma cases showed patchy, 1+ nuclear immunoreactivity for PAX-8. This study confirms the specificity of brachyury for chordoma in the differential diagnostic distinction from the potential genitourinary mimics, germ cell tumors and metastatic clear cell renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21102418     DOI: 10.1038/modpathol.2010.196

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  12 in total

Review 1.  Proximal tibial extra-axial chordoma masquerading as renal cell carcinoma metastasis.

Authors:  Jennifer Huang; Nicholas Bhojwani; Fredrick D Oakley; Martin I Jordanov
Journal:  Skeletal Radiol       Date:  2017-07-12       Impact factor: 2.199

Review 2.  The notochord: structure and functions.

Authors:  Diana Corallo; Valeria Trapani; Paolo Bonaldo
Journal:  Cell Mol Life Sci       Date:  2015-04-02       Impact factor: 9.261

3.  Update From The 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Nasopharynx.

Authors:  Edward B Stelow; Bruce M Wenig
Journal:  Head Neck Pathol       Date:  2017-02-28

4.  Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis.

Authors:  Jason K Wasserman; Bibianna Purgina; Chi K Lai; Denis Gravel; Alyssa Mahaffey; Diana Bell; Simion I Chiosea
Journal:  Head Neck Pathol       Date:  2016-01-12

Review 5.  Chordoma of the Head and Neck: A Review.

Authors:  Jason K Wasserman; Denis Gravel; Bibianna Purgina
Journal:  Head Neck Pathol       Date:  2017-10-04

Review 6.  Soft Tissue Special Issue: Chondroid Neoplasms of the Skull.

Authors:  A N Flaman; J K Wasserman; D H Gravel; B M Purgina
Journal:  Head Neck Pathol       Date:  2020-01-16

7.  Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases.

Authors:  Markku Miettinen; Zengfeng Wang; Jerzy Lasota; Christopher Heery; Jeffrey Schlom; Claudia Palena
Journal:  Am J Surg Pathol       Date:  2015-10       Impact factor: 6.394

Review 8.  Nuances in the treatment of malignant tumors of the clival and petroclival region.

Authors:  Ahmed Mohyeldin; Daniel M Prevedello; Ali O Jamshidi; Leo F S Ditzel Filho; Ricardo L Carrau
Journal:  Int Arch Otorhinolaryngol       Date:  2014-10

Review 9.  Clival Chordoma: Case Report and Review of Recent Developments in Surgical and Adjuvant Treatments.

Authors:  Ayaz M Khawaja; Anand Venkatraman; Maira Mirza
Journal:  Pol J Radiol       Date:  2017-11-17

Review 10.  Brachyury: a diagnostic marker for the differential diagnosis of chordoma and hemangioblastoma versus neoplastic histological mimickers.

Authors:  Valeria Barresi; Antonio Ieni; Giovanni Branca; Giovanni Tuccari
Journal:  Dis Markers       Date:  2014-01-21       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.